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INTRODUCTION
Epizootic Rabbit Enteropathy (ERE) can be systematically reproduced with an
inoculum composed of an extract of the intestinal contents of sick rabbits (TEC3;
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ABSTRACT: Using 180 35-day-old SPF rabbits, this study used the effectiveness of bacitracin as a tool
for acquiring more information on the various phases of ERE, in particular during the hours following
inoculation. Five groups of animals were used, including 3 treatments with Bacivet S® (bacitracin) at
different times from inoculation, with the standard inoculum TEC3. Three parameters were studied:
growth, mortality and stomach noises (borborygmi). A significant fall in growth rate was observed
during the first 18 hours following the inoculation in all the inoculated groups, both medicated and not
medicated. Treatment with bacitracin eliminated mortality and borborygmi, but not the initial fall in
growth rate. Treatment starting 18 hours after inoculation is less effective during the acute phase
than the preventive treatment. With a preventive treatment interrupted as soon as 18 hours after
inoculation, a delay of several days was observed before the appearance of the disease (fall in growth
rate, manifestation of borborygmi) and total mortality was reduced. Very few pathogens can explain
this early fall in growth rate. Bacitracin is an antibiotic which offers good control of the disease, and
probably of the pathogen but not of the physio-pathological disturbances in the first few hours. The
intervention of an exogenic toxin in the first hours of contamination seems likely. Borborygmi are
important criteria. The intensity and/or frequency could be used as semi-quantitative criteria to
characterize the disease and for the prognosis. In a simultaneous trial, a group was contaminated
with the same inoculum, heated for 10 min at 55°C, in order  to obtain more information on the type of
pathogen involved in the etiology of ERE. This treatment did not modify the virulence of the inoculum.
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LICOIS and COUDERT, 2001). The disease can be reproduced in the laboratory (LICOIS
et al., 2005) as well as under field conditions (BOISOT et al., 2003). In a previous
work, COUDERT and LICOIS (2004) described ERE as an acute disease, the first
symptoms appearing as early as the first day post-inoculation. The results seemed to
indicate two successive and independent periods during the evolution of the disease:
a very acute phase during the first hours following the inoculation and an acute phase,
four or five days later. Moreover, it as been shown that an antibiotic treatment
completely controls the acute phase but not the symptoms of the very acute phase.
The aim of this work was to study the daily reactions (weight gain, mortality,
borborygmi) of the inoculated animal and the modulation of these reactions by an
antibiotic. We also report an attempt to modify the virulence of the inoculum by
heating.
MATERIAL AND METHODS
Experimental design
Seven groups of animals were used including 4 treatments with Bacivet S®, at
different times, being day 0 the inoculation day (Table 1):
Room A: standard inoculum (TEC3). Study of the early phenomena after inoculation
with the standard inoculum (TEC3):
- Group A1: uninoculated and continuously treated from day -3 to day +15
(Control A; Uninoculated Treated A).
- Group A2: inoculated and never treated (Positive Control A; Inoculated
Untreated A).
- Group A3: inoculated and treated from day -3 to day +15 (Inoculated Treated
A from D-3 to D+15).
- Group A4: inoculated and treated from day -3 to 18 hours after inoculation
(Inoculated Treated A from D-3 to D+1).
- Group A5: inoculated and treated from the 18 hours after inoculation to day
+15 (Inoculated Treated A from D+1 to D+15).231
ERE: EARLY PHENOMENA
Room B: inoculum TEC3 after heating (TEC3H). Study of the virulence of this
inoculum after heating at 55°C, 10 min (bain-marie). This temperature is low but
was selected in order to inhibit the action of certain bacterial toxins such as Clostridium
perfringens enterotoxin, while preserving the integrity of the vegetative forms.
Clostridium perfringens is a bacterium present in the inoculum TEC (LICOIS et al.,
2005).
- Group B1: uninoculated and continuously treated from day -3 to day +15
(Control B; Uninoculated Treated B).
- Group B2: inoculated with TEC3H and never treated (Positive Control B;
Inoculated Untreated B).
Note: the uninoculated control groups were continuously treated with Bacivet
S®, as otherwise these animals could have been rapidly contaminated because of the
very high contagiousness of this disease.
Animals and experimental facilities
At weaning (35 days) 180 SPF rabbits were selected on the basis of their weight
(x ± 2SD) from a contemporary population of 206 young rabbits. The distribution in
each goup was randomly made in a block structure (weight). The mean weight was
895 ± 129 g.
The cages of metal netting were laid out in batteries on 2 levels. The buildings
were disinfected by gaseous formalin before and after each experiment. The
temperature and the ventilation were controlled. Rooms A and B had the same layout.
Table 1: Experimental design with 5 animals per cage for all groups.
Treatments (Bacitracin)
Room Inoculation No treatment
From D-3
to D+15
From D-3
to D+1
From D+1
to D+15
A Uninoculated (Control A) - A1 (20) - -
A Inoculated TEC3 A2 (25) A3 (25) A4 (25) A5 (25)
B Uninoculated (Control B) - B1 (20) - -
B Inoculated TEC3H 1 B2 (40) - - -
1 Heated 55°C 10 min. No. of animals per treatment in brackets.232
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Inoculation and treatments
The animals were inoculated by oral route with 0,5 ml of the TEC3 inoculum
(LICOIS et al., 2005). The control groups (referred to as “uninoculated” in the text)
also received 0,5 ml of intestinal contents taken from SPF rabbits. The drinking water
of the treated groups contained 0,7 g per litre of Bacivet S®, which corresponds on
average to a consumption of 420 IU of bacitracin per kg of body weight.
Measured parameters
Animal were weighed at distribution in the cages (D-6), then at the beginning of
the treatment (D-3), at inoculation (D0), 18 hours after inoculation (D+1) and D+2,
D+3, D+4, D+5 during the acute period, and finally three times during the period of
convalescence (D+7, D+10 and D+15).
Detection and characterization (+, ++, +++) of borborygmi (bowel rumbling
noises) were carried out at each weighing. Mortality was noted every day and all
animals were necropsied.
Statistical Analysis
The daily weight gains (DWG) were analyzed by variance analysis with 2 factors
(Treatment (5) and block (2)) and Tukey Test, (Systat). Mortality was analyzed by
the test of χ2 .
RESULTS
Mortality
As can be seen in Table 2,  no mortality was observed in the 2 uninoculated
control groups (A1 and B1). There was no mortality in group A3 (inoculated and
continuously treated) and one animal died (4%) in the group where the treatment
began one day after contamination (A4). In the group in which the treatment was
stopped the day after inoculation (A5), the mortality was similar but delayed as
compared with the inoculated untreated group (A2).  Mortality in the inoculated groups
with the heated inoculum (B2) or with the standard inoculum (A2) was similar.233
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Growth
The two uninoculated groups (A1 and B1) showed a similar growth rate (P=0.30)
in whatever room they were placed (Table 3).
The results referring to the effect of the different treatments on the DWG were
analyzed separately for the two experiments:
1. Study of the early phenomena after inoculation with the standard inoculum
(TEC3; room A; Figure 1). The inoculated and untreated group (A2) showed the
expected evolution in growth. The disease showed the characteristic evolution of
ERE with an early fall in growth rate followed by a peak of morbidity toward
D+4, D+5 and a re-establishment starting from D+10. In all the inoculated groups
the growth rate fell significantly before the 18th hour (D+1) (P<0.01). This fall
lasted only one or two days for the treated groups, but as early as D+3 the growth
became not significantly different (P=0.20) to that of the uninoculated control
group (A1). In the group treated shortly after inoculation (A4), the evolution of
Table 2 : Number of animals and percentage of mortality at different groups.
Groups No. of animals Mortality Days of death
A1: Uninoculated Treated A 20 0%
A2: Inoculated Untreated A 25 20% 4 - 5 - 9 - 11- 12
A3: Inoculated Treated A from D-3 to D+15 25 0%
A4: Inoculated Treated A from D+1 to D+15 25 4% 5
A5: Inoculated Treated A from D-3 to D+1 25 20% 7 - 10 - 13 - 14 - 15
B1: Uninoculated Treated B 20 0%
B2: Inoculated Untreated B 1 40 13% 6 - 11 - 13 - 13- 13
1 animals inoculated with TEC3, heated at 55°C, 10 min.
Table 3: Comparison of the mean daily weight gain of the two control groups.
Mean Daily Weight Gain (g) for each period
D-6 to
D-3
D-3 to
D0
D0 to
 D1
D1 to
D3
D3 to
D5
D5 to
 D7
D7 to
D10
D10 to
D15
D-3 to
 D15
Control Room A 25 43 31 38 27 46 32 27 32
Control Room B 28 36 28 45 26 35 45 33 36
Significance NS NS NS NS NS NS NS NS NS234
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growth rate was similar to that of the inoculated non-treated group (A2), for a
few days (D0 to D+5). Subsequently, growth rate was not significantly different
from that of the uninoculated control group (A1). No immediate effect was
observed when the treatment was stopped 18 hours after inoculation (A5). The
growth rate was similar to that of the uninoculated control group (A1) for several
days, before falling significantly after D+5 (P<0.01).
2. Study of the virulence of the TEC3 inoculum after heating at 55°C, 10 min
(TECH; room B; Figure 2). The uninoculated control groups (A1, B1) of both
rooms had the same DWG between D0 and D+15 (A: 32g; B: 36g; P=0.30). The
daily fluctuations of growth rate were also similar. The group inoculated with the
heated inoculum (B2) had the same DWG as the group inoculated with the
unheated inoculum (A2), (D0 to D+15: A2: 24g; B2: 22g; P=0.30).
Diarrhea and stomach noises (borborygmi).
Diarrhea was observed in only one animal (inoculated and untreated group). No
borborygmus was heard either before inoculation in all animals, or on the uninoculated
groups (A1, B1). As can be seen in Figure 3, the first borborygmus was heard on
D+3 in the inoculated and untreated group (A2). In this group borborygmus increased
rapidly and persisted in 20 to 40% of the animals until D+10. The inoculated but
treated groups (A3, A4) had a slight peak of this clinical sign at D+5. The group
Figure 1: Epizootic Rabbit Enteropathy - Study of early fall of daily weight gain.
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treated until one day after inoculation (A5) had practically no clinical signs until the
7th day, but the frequency of borborygmus increased later simultaneously with a
decrease in the growth rate (see Figure 1).
Relationship between borborygmi, weight gain and mortality.
For this analysis we used only the inoculated unmedicated groups (with the
uninoculated groups as reference). The data of the two uninoculated groups (A1+B1)
and of the two inoculated groups were pooled (A2+B2).
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Figure 3: Epizootic Rabbit Enteropathy – Study of a clinical symptom: frequency of
borborygmus.
Figure 2: Effect of the heated inoculum on daily weight gain.
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Inoculated animals were grouped in four classes according to the intensity (+,
++, +++) and the frequency of the borborygmus between D+3 and D+15: Class 1:
no borborygmus; Class 2: slight borborygmus (+), low frequency; Class 3:
borborygmus ++, one or two times; and Class 4: borborygmus +++, several times.
As can be seen  in Figure 4, from D0 to D+1 the fall in growth rate of inoculated
animals was not related to the subsequent appearance of borborigmi. As early as D+1
inoculated animals which later had no borborygmus at all (class 1) had a better weight
gain than those which obtained the highest borborygmus score (class 3 and 4).
Mortality was only observed in the sub group of classes 3 (++) and 4 (+++).
Necropsy
All dead animals presented the typical signs of ERE and no lesion of intercurrent
pathology was observed.
Figure 4: Relationship between borborygmi, weight gain and mortality. Borborygmus
= rumbling sound made by gas and fluids moving throught the stomach + intestines; Inoc
= Inoculated with the inoculum TEC3, for each period, weight gains  indexed with the
same letter are not different (variance analysis and Tukey test: P<0,01).
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DISCUSSION
A significant fall in growth rate was observed less than 24 hours after inoculation
in all the inoculated medicated and non-medicated groups. This early adverse reaction
lasted one or two days and animals recovered between D+2 and D+3. Untreated
animals had a second peak of the disease around D+5, which is in agreement with
the development of ERE (LICOIS et al., 2005; KÜHN, 2005). Further research is needed
to identify with greater precision the rapidity and the origin of this early adverse
reaction of the animal. The aetiology of the two peaks of the disease may be different.
Very few pathogens can explain this early fall in growth rate. Bacitracin is an antibiotic
which makes good control of the disease possible (COUDERT and LICOIS, 2004;
MAERTENS et al., 2005) and thus probably of the pathogen as well, but not the physio-
pathological disturbances of the first few hours. The intervention of an exogenic
toxin, as suggested by MARLIER et al. (2003), as early as the moment of contamination
seems likely.
The preventive and unbroken treatment with bacitracin allowed mortality to be
eliminated and improved the weight gain of inoculated animals, but some borborygmi
appeared at the peak of the disease (D+5). When the preventive treatment was stopped
as early as 18 hours after inoculation, a delay of several days was observed before the
disease appeared (fall in growth rate, manifestation of borborygmi) and total mortality
was reduced. As in our previous work (COUDERT and LICOIS, 2004), the treatment
starting as early as 18 hours after inoculation was less effective during the acute
phase of the disease (D0 to D+5) but it reduced mortality and improved growth after
the 5th day.
Borborygmi are an important criterion since they are representative of the
seriousness of the disease. There are few early symptoms for ERE: diarrhoea is not
constant, caecal compaction appears later and is also inconstant. The intensity and/or
frequency of borborygmi could be used as a semi-quantitative criterion to study the
disease and for prognosis.238
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The inefficacy of heating to destroy an eventual toxin and /or the pathogen itself,
by heating the inoculum for 10 min at 55°C, is demonstrated. Further research is
necessary with higher temperatures or by fractioning of the inoculum, in order to get
more information and to better characterize the unknown pathogen.